品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | T126231-10mg | 10mg | 现货 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
Moligand™, ≥98% |
|
|
阿拉丁 | T126231-50mg | 50mg | 现货 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
Moligand™, ≥98% |
|
|
阿拉丁 | T126231-25mg | 25mg | 现货 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
Moligand™, ≥98% |
|
|
阿拉丁 | T126231-100mg | 100mg | 现货 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
Moligand™, ≥98% |
|
|
麦克林 | T897464-1mg | 1mg | 订前询问 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
≥98% |
|
|
麦克林 | T897464-5mg | 5mg | 订前询问 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
≥98% |
|
|
麦克林 | T897464-10mg | 10mg | 订前询问 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
≥98% |
|
|
麦克林 | T897464-50mg | 50mg | 订前询问 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
≥98% |
|
|
罗恩 | R021657-50mg | 50mg | 5~7个工作日 | 870070-55-6 |
Tozadenant Tozadenant |
98% |
|
|
罗恩 | R021657-10mg | 10mg | 5~7个工作日 | 870070-55-6 |
Tozadenant Tozadenant |
98% |
|
|
MARY | MR132768-10mg | 10mg | 订前咨询 | 870070-55-6 |
Tozadenant Tozadenant |
98% |
|
|
MARY | MR132768-50mg | 50mg | 订前咨询 | 870070-55-6 |
Tozadenant Tozadenant |
98% |
|
|
源叶 | S86923-10mg | 10mg | 期货,请咨询 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
≥98% |
|
|
源叶 | S86923-50mg | 50mg | 期货,请咨询 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
≥98% |
|
|
源叶 | S86923-25mg | 25mg | 期货,请咨询 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
≥98% |
|
|
源叶 | S86923-100mg | 100mg | 期货,请咨询 | 870070-55-6 |
Tozadenant,受体拮抗剂 Tozadenant |
≥98% |
|
|
毕得 | BD234839-250mg | 250mg | 现货 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
99% |
|
|
毕得 | BD234839-10mg | 10mg | 现货 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
99% |
|
|
毕得 | BD234839-50mg | 50mg | 现货 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
99% |
|
|
毕得 | BD234839-100mg | 100mg | 现货 | 870070-55-6 |
4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并... Tozadenant |
99% |
|
|